These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 14411951
1. [On the recognition of drug exanthem caused by oral antidiabetics]. KRESBACH H. Dermatol Wochenschr; 1959 Oct 03; 140():1091-6. PubMed ID: 14411951 [No Abstract] [Full Text] [Related]
2. LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE. BERNHARD H. Diabetes; 1965 Feb 03; 14():59-70. PubMed ID: 14256053 [No Abstract] [Full Text] [Related]
3. Effects of various hypoglycaemic sulphonylureas on the cardiotoxicity of glycosides. Pogátsa G, Koltai MZ, Balkányi I, Dévai J, Kiss V. Eur J Clin Pharmacol; 1985 Feb 03; 28(4):367-70. PubMed ID: 3928386 [Abstract] [Full Text] [Related]
4. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)]. BERNHARD H. Arzneimittelforschung; 1964 May 03; 14():411-2. PubMed ID: 14238602 [No Abstract] [Full Text] [Related]
5. [OUR EXPERIENCES WITH ORAL ANTIDIABETICS IN OUTPATIENT CONTROL AND TREATMENT OF DIABETIC PATIENTS]. ANGELI I. Orv Hetil; 1964 Nov 15; 105():2186-90. PubMed ID: 14216805 [No Abstract] [Full Text] [Related]
6. [SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS]. OSTMAN J, GROENBERG A. Nord Med; 1964 Nov 19; 72():1388-95. PubMed ID: 14210083 [No Abstract] [Full Text] [Related]
8. [CLINICAL STUDIES OF THE EFFECTS OF ORAL ANTIDIABETICS IN THE FETUS]. STERNE J, LAVIEUVILLE M. Diabete; 1963 Nov 19; 11():292-4. PubMed ID: 14082976 [No Abstract] [Full Text] [Related]
9. ORAL TREATMENT OF DIABETES MELLITUS. BURNS FH. Med J Aust; 1963 Nov 09; 2():783-5. PubMed ID: 14075568 [No Abstract] [Full Text] [Related]
11. [Comparative hypoglycemic effect of sulfonamide mixtures. Carbutamide (BZ-55), tolbutamide (D-860). chlorpropamide (P-607). in patients with diabetes mellitus]. HERNANDEZ JAUREGUI R. Medicina (Mex); 1959 Dec 25; 39():553-61. PubMed ID: 13852274 [No Abstract] [Full Text] [Related]
12. [THE MECHANISM OF ACTION OF PERORAL ANTIDIABETICS]. HORN Z. Bull Schweiz Akad Med Wiss; 1965 Feb 25; 21():67-76. PubMed ID: 14256856 [No Abstract] [Full Text] [Related]
13. [POSSIBILITIES OF ORAL DIABETES THERAPY]. MEHNERT H, MAHRHOFER E, KAISER W. Ther Ggw; 1964 Jan 25; 103():21-33. PubMed ID: 14127811 [No Abstract] [Full Text] [Related]
14. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC]. GUTSCHE H, BOENICKE G. Arzneimittelforschung; 1964 May 25; 14():409-11. PubMed ID: 14238601 [No Abstract] [Full Text] [Related]
15. CARBUTAMIDE and tolbutamide in the treatment of diabetes. Med J Aust; 1957 Dec 14; 44(24):865-6. PubMed ID: 13492803 [No Abstract] [Full Text] [Related]
17. In vitro effects of carbutamide and tolbutamide on isolated frog muscle. GOURLEY DR, DODD RH. Am J Physiol; 1958 Mar 14; 192(3):471-5. PubMed ID: 13520936 [No Abstract] [Full Text] [Related]
18. [ON THE PROBLEM OF LIMITED EFFECTIVENESS OF SULFANYLUREA THERAPY IN DIABETES MELLITUS]. LUSCHNITZ E, SEIGE K, MUEHLBERG H. Z Gesamte Inn Med; 1965 Jan 15; 20():SUPPL:255-6 C. PubMed ID: 14262358 [No Abstract] [Full Text] [Related]